1/16/25 12:05 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 254 | 11.03 | 0 | 23 | 9 | 269 | D | | | | | | | | | | | | | | |
10/29/24 13:01 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 535 | 13.81 | 0 | 39 | 19 | 246 | D | | | | | | | | | | | | | | |
10/15/24 11:51 | 10/14/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 44 | 14.43 | 0 | 3 | 1 | 219 | D | | | | | | | | | | | | | | |
10/15/24 09:21 | 10/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D | | | | | | | | | | | | | | |
10/9/24 13:35 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 496 | 15.07 | 0 | 33 | 19 | 202 | D | | | | | | | | | | | | | | |
4/26/24 12:50 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 25 | 11.96 | 0 | 2 | 1 | 171 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
9/28/22 17:27 | 9/28/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 316 | 14.37 | 0 | 22 | 38 | 80 | D | | | | | | | | | | | | | | |
8/2/22 14:28 | 7/29/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 404 | 23.07 | 0 | 18 | 43 | 58 | D | | | | | | | | | | | | | | |
4/1/21 21:19 | 3/31/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | M.d | 2,555 | 63.13 | 0 | 40 | | 20 | D | | | | | | | | | | | | | | |
4/1/21 21:19 | 3/31/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | S.d | -3,560 | 87.99 | 0 | -40 | -67 | 20 | D | | | | | | | | | | | | | | |
4/1/21 18:40 | 3/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | M.d | 598 | 62.70 | 0 | 10 | 90 | 20 | D | | | | | | | | | | | | | | |
4/1/21 18:40 | 3/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | S.d | -830 | 87.09 | 0 | -10 | -32 | 20 | D | | | | | | | | | | | | | | |
4/1/21 18:32 | 3/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | M.d | 255 | 63.71 | 0 | 4 | 25 | 20 | D | | | | | | | | | | | | | | |
1/8/21 09:24 | 1/7/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | M.d | 2,710 | 67.74 | 0 | 40 | | 16 | D | | | | | | | | | | | | | | |
3/27/20 18:12 | 3/25/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | DO | P,CEO | P | 102 | 58.24 | 0 | 2 | 12 | 16 | D | | | | | | | | | | | | | | |
3/27/20 18:08 | 1/8/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | DO | P,CEO | P | 99 | 65.40 | 0 | 2 | 12 | 14 | D | | | | | | | | | | | | | | |
8/7/19 11:01 | 8/5/19 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | O | P,CEO | M.d | 2,052 | 51.29 | 0 | 40 | | 13 | D | | | | | | | | | | | | | | |
8/7/19 11:01 | 8/5/19 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | O | P,CEO | S.d | -2,174 | 69.03 | 0 | -31 | -71 | 13 | D | | | | | | | | | | | | | | |
9/28/18 20:56 | 9/26/18 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | O | P,CEO | P | 316 | 73.58 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |